CT Cardiomegaly vs AVIEW Lung Nodule CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CT Cardiomegaly

by Innolitics

AVIEW Lung Nodule CAD

by Coreline Soft

AI Verdict

Innolitics' CT Cardiomegaly is a specialized tool for automatically measuring cardiothoracic ratio to detect cardiomegaly. Coreline Soft Co.'s AVIEW Lung Nodule CAD, while also analyzing chest CTs, offers a broader scope, focusing on lung nodule detection, emphysema, and coronary artery calcification. Therefore, they are adjacent tools, as they both utilize AI for chest CT analysis but address different primary clinical concerns.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if your primary objective is automated, quantitative assessment of cardiomegaly from CT chest images. This tool is ideal for clinics or research settings requiring precise cardiothoracic ratio measurements to support diagnostic decisions and track cardiac enlargement.

View CT Cardiomegaly →

Choose AVIEW Lung Nodule CAD if…

Choose AVIEW Lung Nodule CAD if you require a comprehensive AI solution for multi-faceted chest CT analysis, beyond just cardiomegaly. This tool is best suited for practices focused on lung cancer screening, COPD assessment, and cardiovascular risk stratification, offering simultaneous detection and quantification of lung nodules, emphysema, and coronary artery calcification.

View AVIEW Lung Nodule CAD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CT Cardiomegaly	AVIEW Lung Nodule CAD
Pricing	Fixed-fee	Unknown
Deployment	Docker Container (Ubuntu 20.04), command-line software	On-premises and cloud environment
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AVIEW Lung Nodule CAD

Tool A is described as 'command-line software' deployed via Docker, suggesting a more technical user experience. Tool B, while not explicitly detailing its interface, is designed to 'assist radiologists' and offers 'automatic report generation,' implying a more integrated and user-friendly graphical interface suitable for clinical workflows.

Clinical Value

AVIEW Lung Nodule CAD

Tool B offers significantly broader clinical utility by simultaneously analyzing lung nodules, emphysema, and coronary artery calcification (the 'Big 3') from a single CT scan, providing comprehensive insights for lung cancer, COPD, and cardiovascular risk. Tool A, while valuable, focuses on a single measurement for cardiomegaly detection.

Pricing & Value

Tie

Both tools state 'contact for pricing,' and neither provides public details on their pricing models or specific cost-saving benefits. Without transparent pricing information, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

AVIEW Lung Nodule CAD

Tool B offers more flexible deployment options, including cloud-based, hybrid, local hardware, and virtualized solutions, which caters to diverse enterprise IT infrastructures. Tool A's command-line Docker deployment, while robust, may require more specialized integration efforts into existing clinical systems.

Innovation

AVIEW Lung Nodule CAD

Tool B demonstrates greater innovation by integrating the simultaneous analysis of lung nodules, emphysema, and coronary artery calcification into a single solution, offering a multi-faceted risk assessment. Tool A provides a valuable, but more focused, single quantitative measurement for cardiomegaly.

Support & Docs

Tie

The provided structured facts for both Tool A and Tool B do not contain any specific information regarding their support services, documentation availability, or customer service channels. Therefore, a meaningful comparison on this dimension is not possible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CT Cardiomegaly	AVIEW Lung Nodule CAD
Name	CT Cardiomegaly	AVIEW Lung Nodule CAD
Company	Innolitics	Coreline Soft Co.
Primary Use Case	FDA-cleared AI-powered command-line software that automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data.	AI-powered software that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification.
Target Specialties	Cardiology, Radiology	Cardiology, Pulmonology, Radiology
Key AI Functionality	Automatic cardiothoracic ratio measurement; Machine learning algorithms for segmentation; Segmentation of heart and thoracic cavity; Calculates linear and area-based cardiothoracic ratios.	AI-based pulmonary nodule detection (3-20 mm); Nodule classification (solid, part-solid, non-solid); 3D nodule size and volume quantification; Nodule matching and volume doubling time (VDT) calculation; Quantitative emphysema analysis; Coronary Artery Calcification (CAC) scoring.
Output/Reporting	Outputs PDF and JSON reports	Automatic report generation based on Lung-RADS classification

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and AVIEW Lung Nodule CAD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of each tool?

Tool A, Innolitics' CT Cardiomegaly, is designed to automatically measure the cardiothoracic ratio from CT chest images to assist in cardiomegaly detection. Tool B, AVIEW Lung Nodule CAD by Coreline Soft Co., assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification.

What specific quantitative measurements or analyses do these tools provide?

Tool A focuses on calculating linear and area-based cardiothoracic ratios. Tool B provides AI-based pulmonary nodule detection (3-20 mm), nodule classification (solid, part-solid, non-solid), 3D nodule size and volume quantification, nodule matching and volume doubling time (VDT) calculation, quantitative emphysema analysis (e.g., Low Attenuation Area - LAA, emphysema index), and coronary artery calcification (CAC) scoring (Agatston, volume, mass scores).

Which medical specialties are these tools designed to support?

Both Tool A and Tool B are designed to support Cardiology and Radiology specialties. Additionally, Tool B also supports Pulmonology.

What kind of reporting and output can I expect from each tool?

Tool A outputs PDF and JSON reports containing cardiothoracic ratio measurements. Tool B generates automatic reports based on Lung-RADS classification and provides various quantitative scores for nodules, emphysema, and coronary artery calcification.

Is there a difference in how the AI models are described or validated?

Tool A uses non-adaptive machine learning algorithms with the MONAI framework and has been validated against manual measurements by board-certified radiologists. Tool B is described as AI-powered, utilizing deep learning CAD systems, and has clinical trial evidence to evaluate its effectiveness, with performance comparisons to reading specialists.